Article Details

Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021

Retrieved on: 2021-06-02 00:00:00

Tags for this article:

Click the tags to see associated articles and topics

Antengene Announces Abstracts on Twelve Clinical Studies of Selinexor Selected by EHA 2021. View article details on hiswai:

Excerpt

Selinexor containing regimens in patients with multiple myeloma previously treated with anti-CD38 monoclonal antibodies. Abstract #: EP1002.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up